文献速递儿童呼吸儿童心血管与肾脏儿童内分泌与遗传代谢

儿童肺动脉高压的遗传流行病学特征

The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension.
PubMed 文献 · J Pediatr · 2020-06-02

该研究基于荷兰国家注册队列,对70例儿童肺动脉高压患者进行PAH相关基因靶向测序及拷贝数变异检测,发现27%携带PAH相关基因突变/变异,17%存在与PAH明确相关的遗传病,23%存在与PAH无明确相关的遗传病;不同组别生存率存在差异,TBX4变异携带者生存率最有利。

要点

  • 儿童PAH中PAH相关基因突变/变异检出率为27%,以BMPR2和TBX4最常见。
  • 17%患儿合并与PAH明确相关的遗传病,如唐氏综合征和钴胺素C缺乏症。
  • 23%患儿存在与PAH无明确相关的遗传病,包括Noonan综合征、Beals综合征及拷贝数变异。

核心结论

  • 儿童PAH患者中遗传病患病率高,且不限于已确定的PAH相关基因。
  • 遗传结构可能在儿童PAH风险分层管理中发挥作用。

研究设计与样本

  • 研究纳入荷兰国家注册队列中70例诊断为特发性PAH、遗传性PAH、PAH相关先天性心脏病伴巧合分流(PAH-先天性心脏病第3组)、心脏分流关闭后PAH(PAH-先天性心脏病第4组)或PAH相关其他非心脏疾病的儿童。
  • 对PAH相关基因(BMPR2、ACVRL1、EIF2AK4、CAV1、ENG、KCNK3、SMAD9和TBX4)进行靶向下一代测序,临床怀疑时检测特定遗传病,并检测拷贝数变异。

主要发现

  • 另16例儿童(23%)发现与PAH无明确相关的遗传病,包括Noonan综合征、Beals综合征及各种拷贝数变异。
  • 各组间生存率存在差异,TBX4变异携带者生存率最有利。

临床怎么用

  • 对儿童PAH患者应关注PAH相关基因及拷贝数变异检测,并警惕合并遗传综合征的可能。
  • 遗传检测结果可能辅助风险分层管理,TBX4变异携带者预后相对较好。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the prevalence of pulmonary arterial hypertension (PAH)-associated gene mutations, and other genetic characteristics in a national cohort of children with PAH from the Dutch National registry and to explore genotype-phenotype associations and outcomes. STUDY DESIGN: Children (n = 70) diagnosed with idiopathic PAH, heritable PAH, PAH associated with congenital heart disease with coincidental shunt (PAH-congenital heart disease group 3), PAH after closure of a cardiac shunt (PAH-congenital heart disease group 4), or PAH associated with other noncardiac conditions were enrolled. Targeted next-generation sequencing was performed on PAH-associated genes (BMPR2, ACVRL1, EIF2AK4, CAV1, ENG, KCNK3, SMAD9, and TBX4). Also, children were tested for specific genetic disorders in case of clinical suspicion. Additionally, children were tested for copy number variations. RESULTS: Nineteen children (27%) had a PAH-associated gene mutation/variant: BMPR2 n = 7, TBX4 n = 8, ACVRL1 n = 1, KCNK3 n = 1, and EIF2AK4 n = 2. Twelve children (17%) had a genetic disorder with an established association with PAH (including trisomy 21 and cobalamin C deficiency). In another 16 children (23%), genetic disorders without an established association with PAH were identified (including Noonan syndrome, Beals syndrome, and various copy number variations). Survival rates differed between groups and was most favorable in TBX4 variant carriers. CONCLUSIONS: Children with PAH show a high prevalence of genetic disorders, not restricted to established PAH-associated genes. Genetic architecture could play a role in risk-stratified care management in pediatric PAH.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Haarman MG, Kerstjens-Frederikse WS, Vissia-Kazemier TR, et al. The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension. J Pediatr. 2020. PMID: 32502478. doi:10.1016/j.jpeds.2020.05.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。